Anrukinzumab (IMA-638) is a humanized monoclonal antibody designed for the treatment of asthma.Statement On A Nonproprietary Name Adopted By The USAN Council:…
Anrukinzumab (IMA-638) is a humanized monoclonal antibody designed for the treatment of asthma.Statement On A Nonproprietary Name Adopted By The USAN Council: Anrukinzumab, American Medical Association. It targets IL-13.
Anrukinzumab was developed by Wyeth.
References
Gebaseerd op: Wikipedia — Anrukinzumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.